Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013


Medical Affairs Seminar - Launching a High-Value Medical & Scientific Affairs Team

22 Jan 2013 - 23 Jan 2013 - Boston, MA, USA



Bookmark and Share


Medical Affairs Seminar - Launching A High-Value Medical & Scientific Affairs Team

During the past decade, Medical Affairs has become a critical function within all pharmaceutical and biotechnology companies. A high-performance Medical Affairs team will not only support but drive the safe, effective and appropriate use of medications throughout a product lifecycle. A Medical Affairs Department is now a necessity rather than a luxury. 

Launching a High Value Medical Affairs Team is an interactive learning opportunity for professionals who are setting up, expanding or restructuring Medical Affairs Departments and Groups. This program will help participants identify the needs of their organization, the appropriate structure and organizational alignment and identify critical functions, and will clarify many other operational aspects that are key to building a sustainable and respected department.

This conference will offer an opportunity to learn from others who have built Medical Affairs teams from the ground up, including the good, the bad and the ugly. Finally, and most important, the seminar is an excellent opportunity to pause from everyday duties, in order to reflect on your medical affairs strategies and tactics, and exchange experiences through networking and discussion with your peers.



Further information
Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!